Abstract:As normal tissues contain normal tissue stem cells (NSCs), tumors are thought to contain tumor stem cells (TSCs) which perform self-renewal and generate their progenies. TSC can be a therapeutic target; however, cancer therapies targeting TSCs are limited, because most of the TSC markers are shared by NSCs. Therefore, it is important to identify TSC-specific markers. Previously, we reported that doublecortin-like kinase 1 (Dclk1)-positive epithelial cells do not produce any progenies in the normal small intestine but supply progeny tumor cells in the tumors of Apc mice. Selective ablation of Dclk1-positive TSCs collapses the intestinal tumors of Apc mice. Therefore, Dclk1 appears to be a specific marker of TSCs in the mouse intestinal tumors. In the present study, we performed microarray analysis in order to investigate the characteristics of Dclk1-positive TSCs in the tumors of Apc mice. Dclk1-positive tumor cells had higher expression levels of cyclooxygenase 1 (Cox1), leukotriene C4 synthase (Ltc4s), and arachidonate 5-lipoxygenase activating protein (Alox5ap) than Dclk1-negative cells in the tumors of Apc mice, suggesting that Dclk1positive cells in the tumors of Apc mice had higher expression levels of the genes which were related to prostaglandin and leukotriene metabolism. As well, microarray analysis revealed that gustducin alpha and gamma subunits, transient receptor potential cation channel, subfamily M, member 5 (TRPM5), and phospholipase C beta 2 were more highly expressed in Dclk1-positive tumor cells. Thus, Dclk1-positive tumor cells seemed to possess the characteristic of Tuft cells. Furthermore, Dclk1-positive tumor cells had higher expression level of Ras-related C3 botulinum toxin substrate 2 (Rac2) than Dclk1-negative tumor cells in Apc mouse intestine. In order to elucidate the role of Rac2 in Dclk1-positive TSCs, we generated tumor spheroids from Apc mouse tumors, and administrated EHT1864, Rac inhibitor to the spheroids. Following 5-day treatment with EHT1864, the growth of the tumor spheroids was significantly suppressed. Importantly, on day1, EHT1864 treatment significantly reduced the proportion of Dclk1-positive cells in the tumor spheroids. These results suggested that Rac2 played some roles for the maintenance of the intestinal tumor spheroids. In conclusion, this study may provide new insights into the maintenance mechanisms of Dclk1-positive TSC in the intestinal tumors, and give us hints to develop novel therapeutic strategies targeting TSCs against colorectal cancers.

Restraining Wnt activation and intestinal tumorigenesis by a Rab35 dependent GTPase relay

Su2003 Nrip2, a Novel Regulator of the Non-Canonical Wnt Pathway, Promotes the Self-Renewal of Colorectal Cancer Initiating Cells

Up-regulated NRIP2 in Colorectal Cancer Initiating Cells Modulates the Wnt Pathway by Targeting RORβ.

Twa1/Gid8 is a Β-Catenin Nuclear Retention Factor in Wnt Signaling and Colorectal Tumorigenesis

Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer

Wnt signalling in the mouse intestine

Nuclear receptor binding protein 1 regulates intestinal progenitor cell homeostasis and tumour formation

Targeting the Wnt signaling pathway in colorectal cancer

Interaction between Wnt/β-catenin and RAS-ERK pathways and an anti-cancer strategy via degradations of β-catenin and RAS by targeting the Wnt/β-catenin pathway

RhoA downregulation in the murine intestinal epithelium results in chronic Wnt activation and increased tumorigenesis

The Orphan Receptor TR3 Suppresses Intestinal Tumorigenesis in Mice by Downregulating Wnt Signalling

Distinct CRC-associated APC mutations dictate response to Tankyrase inhibition.

Wnt/β-catenin signaling in colorectal cancer: Is therapeutic targeting even possible?

Tumour Suppressor ABCA8 Inhibits Malignant Progression of Colorectal Cancer Via Wnt/β-catenin Pathway.

ZEB1 and TCF4 Reciprocally Modulate Their Transcriptional Activities to Regulate Wnt Target Gene Expression

Rab1A Promotes Proliferation and Migration Abilities Via Regulation of the HER2/AKT-independent Mtor/s6k1 Pathway in Colorectal Cancer.

APC controls Wnt-induced β-catenin destruction complex recruitment in human colonocytes

Wnt signaling dosage controlled by a enhancer balances homeostasis and tumorigenesis of intestinal epithelia

An MST4-pβ-CateninThr40 Signaling Axis Controls Intestinal Stem Cell and Tumorigenesis.

Nuclear partitioning of Prohibitin 1 inhibits Wnt/β-catenin-dependent intestinal tumorigenesis

Wnt signaling in colorectal cancer: pathogenic role and therapeutic target